[Evaluation of fifteen months' activity in an ambulatory surgery center in a university hospital].

J. Wasserfallen,J. Absi,D. Hude,P. Ravussin

1997-05-01

Abstract:

What problem does this paper attempt to address?

Azidothymidine Downregulates Insulin-Like Growth Factor-1 Induced Lipogenesis by Suppressing Mitochondrial Biogenesis and Mitophagy in Immortalized Human Sebocytes

Jin Gwi Yoo,Xue Mei Li,Jae Kyung Lee,Sanghyun Park,Dongkyun Hong,Kyung Eun Jung,Young Lee,Young-Joon Seo,Chang Deok Kim,Jung-Min Shin,Chong Won Choi

DOI: https://doi.org/10.5021/ad.2021.33.5.425

Abstract:Background: Increased sebum secretion is considered the main causative factor in the pathogenesis of acne. There is an unmet pharmacological need for a novel drug that can control sebum production with a favorable adverse effect profile. Objective: To investigate the effect of azidothymidine on lipid synthesis in sebocytes and to identify the underlying mechanism of the inhibitory effect of azidothymidine on insulinlike growth factor (IGF)-1-induced lipid synthesis in sebocytes. Methods: Immortalized human sebocytes were used for the analysis. Thin-layer chromatography (TLC) and Oil Red O staining were performed to evaluate lipid synthesis in the sebocytes. The differentiation, lipid synthesis, mitochondrial biogenesis, and mitophagy in sebocytes were investigated. Results: TLC and Oil Red O staining revealed that azidothymidine reduced IGF-1 induced lipid synthesis in the immortalized human sebocytes. Azidothymidine also reduced IGF-1-induced expression of transcriptional factors and enzymes involved in sebocyte differentiation and lipid synthesis, respectively. Moreover, we found that IGF-1 upregulated the levels of peroxisome proliferator-activated receptorgamma coactivator-1α, LC-3B, p62, and Parkin, major regulators of mitochondrial biogenesis and mitophagy in immortalized human sebocytes. In contrast, azidothymidine inhibited IGF-1 induced mitochondrial biogenesis and mitophagy in the sebocytes. Conclusion: These results suggest that azidothymidine downregulates IGF-1-induced lipogenesis by dysregulating the quality of mitochondria through suppression of mitochondrial biogenesis and mitophagy in immortalized human sebocytes. Our study provides early evidence that azidothymidine may be an effective candidate for a new pharmacological agent for controlling lipogenesis in sebocytes.
Conscious mind as a field.

B. Libet

DOI: https://doi.org/10.1006/JTBI.1996.0019

IF: 2.405

1996-01-21

Journal of Theoretical Biology

Abstract:In the Special issue on ‘‘Mind and Matter’’, the paper by Lindahl & A rhem (1994) presented an interesting and provocative discussion of ‘‘mind as a force field’’. This was based on the proposal by Karl Popper (Popper et al., 1993) that minds have important similarities to recognized physical forces. Popper hypothesized that ‘‘electro-magnetic wave fields (produced by neural activities) . . . represent the unconscious parts of our minds, and that the conscious mind—our conscious mental intensities, our conscious experiences—are capable of interacting with these unconscious physical force fields . . .’’. Lindahl & A rhem (1994) faced up to and fruitfully dealt with a number of philosophical issues raised by the proposition of a ‘‘mental force field’’. I had myself proposed the hypothetical existence of a ‘‘conscious mental field’’ (CMF; Libet 1993b, 1994). The CMF would emerge as a function of appropriate neural activities in the brain; it would have the attribute of conscious subjective experience; it could act back on certain neural activities and therefore affect the behavioral outcome, as in a willed action; it would account for the unity of subjective experience even though the latter emerges from the myriad of activities of billions of nerve cells and their synaptic and non-synaptic interplays. The CMF, like the subjective experiences constituted in it, would be accessible only to the individual having the experiences; it could not be directly observed by any external physical device except indirectly, by any effects it introduces on behavioral outcomes (just as conscious will is evidenced). I would like to analyse some aspects of Popper’s proposals, as elaborated by Lindahl & A rhem, and contrast them with my CMF proposal. I like Popper’s idea of viewing the mind as a kind of force field. My CMF could also be viewed in that way; such a CMF force would then have to be different from all known physical forces. Popper’s hypothesis does not appear to spell out any attributes of that conscious force field except its ability to interact with another entity, the brain’s electromagnetic field which belongs to his physical World 1. Popper’s view, that this electromagnetic field represents the unconscious aspects of mental function, is doubtful based on the evidence available. We have demonstrated (Libet et al., 1991) that the transition between an unconscious and a conscious mental operation can simply be a function of a longer duration of similar cerebral activations to achieve awareness. Furthermore, the ‘‘need for what we call attention’’ was similar in all our experimental trials, whether the mental event was an unconscious or a conscious one, so that the attention process does not necessarily distinguish between the two mental states. Electrophysiological activities and responses accompany both unconscious and conscious mental functions. However, these recordable activities must go on for a longer period of time in order for awareness to appear. In the case of sensory input from the skin, production of the slower late components of the evoked cerebral potentials (lasting 0.5 s or more) is necessary for the input to elicit a conscious sensory experience (Libet, 1973; Libet et al., 1967, 1975). Although stimulation of a single mechanoreceptor unit in the hand may elicit a sensation (Ochoa & Torebjörk, 1983), that single peripheral nerve impulse would have to lead to a 0.5 s cascade of early and late electrophysiological responses in the cerebral cortex to have produced a sensory experience. In short, it would appear that both unconscious and conscious mental events could be correlated with or represented by electromagnetic fields of brain activity. Popper’s distinction between conscious and unconscious functions by representing the unconscious ones with a physical electromagnetic field seems to be meaningless. Popper’s proposal of a conscious mental force field arising as a distinctive entity (his World 2) of the physical brain (World 1) is a more supportable one. Indeed, that proposal can be considered similar to my proposed CMF. However, there is no reason to regard such a field as one which is not correlated to specific electromagnetic manifestations of neural
Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili

L. Pratt,R. Kolter

DOI: https://doi.org/10.1046/j.1365-2958.1998.01061.x

1998-10-01

Molecular Microbiology

Abstract:We have used Escherichia coli as a model system to investigate the initiation of biofilm formation. Here, we demonstrate that E. coli forms biofilms on multiple abiotic surfaces in a nutrient‐dependent fashion. In addition, we have isolated insertion mutations that render this organism defective in biofilm formation. One‐half of these mutations was found to perturb normal flagellar function. Using defined fli, flh, mot and che alleles, we show that motility, but not chemotaxis, is critical for normal biofilm formation. Microscopic analyses of these mutants suggest that motility is important for both initial interaction with the surface and for movement along the surface. In addition, we present evidence that type I pili (harbouring the mannose‐specific adhesin, FimH) are required for initial surface attachment and that mannose inhibits normal attachment. In light of the observations presented here, a working model is discussed that describes the roles of both motility and type I pili in biofilm development.
Paeoniflorin mitigates insulin-like growth factor 1-induced lipogenesis and inflammation in human sebocytes by inhibiting the PI3K/Akt/FoxO1 and JAK2/STAT3 signaling pathways

Chuanchuan Cai,Si Liu,Yufeng Liu,Shaobin Huang,Shiya Lu,Fang Liu,Xiaohua Luo,Christos C. Zouboulis,Ge Shi

DOI: https://doi.org/10.1007/s13659-024-00478-4

2024-10-01

Natural Products and Bioprospecting

Abstract:Insulin-like growth factor-1 (IGF-1) is considered as a pathogenic factor contributing to sebaceous gland dysfunction, which leads to acne vulgaris. Paeoniflorin (Pae), a bioactive monomer derived from total glycosides of paeony, has shown potential in treating various diseases. However, its anti-acne effects on human sebocytes are not well understood. In this study, we investigated the effects of Pae on acne development induced by IGF-1 in SZ95 sebocytes. Following IGF-1 stimulation, SZ95 sebocytes were exposed to Pae and then determined for proliferation, cell cycle, apoptosis, lipogenesis and pro-inflammatory cytokine secretion. We also analyzed the expression of proteins involved in the PI3K/Akt/FoxO1 and JAK2/STAT3 pathways. In vitro experiments demonstrated that Pae significantly inhibited colony formation, induced G1/S cell cycle arrest, promoted apoptosis, inhibited lipogenesis and cytokine synthesis in IGF-1-treated SZ95 sebocytes. Furthermore, Pae suppressed the phosphorylation of Akt, FoxO1, JAK2, and STAT3. Importantly, the sebo-suppressive and anti-inflammatory effects of Pae were enhanced by blocking PI3K and JAK2. In summary, our findings suggest that Pae has potent anti-proliferative and pro-apoptotic effects in SZ95 sebocytes. Additionally, Pae effectively protects against IGF-1-induced lipogenesis and inflammation by targeting the PI3K/Akt/FoxO1 and JAK2/STAT3 signaling pathways. Graphical

chemistry, medicinal
Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes

Si Liu,Xiao-Hua Luo,Yu-Feng Liu,Christos C. Zouboulis,Ge Shi

DOI: https://doi.org/10.1038/s41598-023-48709-x

IF: 4.6

2023-12-08

Scientific Reports

Abstract:Emodin, a natural anthraquinone derivative, possesses anti-proliferative and anti-inflammatory properties in skin diseases. However, little information is available on the efficacy of emodin in treating acne vulgaris (acne). This study aims to investigate the protective effects and potential mechanisms of emodin as an anti-acne agent. In vitro, SZ95 sebocytes was chose to establish an acneigenic cellular model. We found that emodin effectively inhibited proliferation, induced cell cycle arrest and apoptosis of SZ95 sebocytes in a dose-dependent manner. To evaluate the lipid-lowering potential of emodin, we examined the levels of lipid contents and lipogenic transcription factors, and found that both lipid production and protein expression of PPARγ, LXR α/β, and SREBP-1 were decreased after treatment with emodin. Furthermore, our results revealed that emodin inhibited sebaceous lipogenesis induced by insulin-like growth factor 1 (IGF-1), which was accompanied by a potent inhibition of the phosphoinositide-3-kinase (PI3K)/Akt/forkhead box protein O1 (FoxO1) pathway. In detail, emodin augmented the inhibitory effect of isotretinoin and PI3K inhibitor LY294002, while attenuating the activation of IGF-1 on PI3K/Akt/FoxO1 pathway. In addition, emodin could decrease the secretion of pro-inflammatory cytokines IL-6 and IL-8, and suppress the expression of NLRP3, capase-1, IL-1β, and IL-18 in SZ95 sebocytes exposed to Cutibacterium acnes . Overall, our study provides preliminary evidence supporting the anti-growth, anti-lipogenic and anti-inflammatory properties of emodin, indicating the potential therapeutic application of emodin for acne treatment.

multidisciplinary sciences
Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro

K Seiffert,H Seltmann,M Fritsch,C C Zouboulis

DOI: https://doi.org/10.1055/s-2007-961814

Abstract:Inhibition of 5alpha-reductase type 1 has been considered to be a promising target for treatment of androgen-dependent skin disorders, however, currently published clinical results on acne treatment are rather disappointing. In this study, the influence of selective inhibitors of 5alpha-reductase on testosterone metabolism within SZ95 sebocytes and HaCaT keratinocytes IN VITRO was investigated. In both cell types, the isotype 1 inhibitor MK386 completely inhibited the conversion of testosterone to 5alpha-dihydrotestosterone in concentrations higher than 10 (-9) M. Inhibitors of the isotype 2 such as finasteride, dihydrofinasteride, and turosteride, were >100-fold less active, while, as expected, androgen receptor inhibitors did not affect the 5alpha-reductase activity. MK386, but not finasteride, reduced testosterone-stimulated proliferation and slightly reduced the testosterone-induced increase in the amount of SZ95 sebocyte proteins. The androgen receptor inhibitor cyproterone acetate exhibited no effect on testosterone-induced proliferation, but inhibited the 5alpha-dihydrotestosterone-induced sebocyte proliferation. Our experimental findings and the existing clinical results indicate that the inhibition of 5alpha-reductase activity alone may be insufficient to reduce overall sebocyte activity and improve acne lesions.
Formalin-killed Propionibacterium acnes activates the aryl hydrocarbon receptor and modifies differentiation of SZ95 sebocytes in vitro

Ke Cao,Guangjie Chen,WenChieh Chen,Xiaoxiao Hou,Tingting Hu,Lingyi Lu,Lanqi Wang,Zhanyan Pan,Qiong Wu,Xin Li,Ziyu Wei,Ying Ma,Christos C Zouboulis,Qiang Ju

DOI: https://doi.org/10.1684/ejd.2021.3964

2021-02-01

Abstract:Background: Acne vulgaris is a common pilosebaceous disease associated with Propionibacterium acnes (P. acnes). Resolution of comedones may occur in association with shrunken sebaceous glands (SGs) containing de-differentiated cells, however the role of P. acnes is unclear. Objectives: To investigate the effects of P. acnes on aryl hydrocarbon receptor (AhR) activation, lipogenesis and differentiation in cultured immortalized human SZ95 sebocytes. Materials & methods: Cultured sebocytes were incubated with formalin-killed (f-) P. acnes (f-P. acnes) at different ratios of multiplicity of infection. The mRNA levels of the AhR downstream cytochrome P450 (CYP) genes were measured by quantitative RT-PCR, nuclear translocation of AhR by western blot and immunofluorescence, lipogenesis and keratinization by gene set enrichment analysis (GSEA), lipid related analysis by Oil red O staining and Nile red staining, and sebaceous differentiation-related gene expression by western blot. Results: f-P. acnes upregulated CYPs mRNA levels and induced translocation of AhR protein from the cytoplasm into the nucleus. GSEA revealed downregulation of lipogenesis and upregulation of keratinization. f-P. acnes inhibited linoleic acid-induced neutral lipid synthesis and expression of sebocyte markers, keratin 7 and mucin1/EMA, but increased expression of keratinocyte markers, keratin 10 and involucrin, which were abolished by AhR gene silencing. Inhibition of lipogenesis-related genes, such as sterol response element-binding protein, was also observed. Conclusion: f-P. acnes inhibits lipogenesis and induces terminal differentiation of sebocytes, into keratinocyte-like cells, via activation of the AhR pathway in vitro, suggesting that follicular P. acnes is not only acnegenic but also promotes acne remission through feedback regulation of sebum production.
[Dealing with patient dissatisfaction; a professional skill].

J. B. Gravenhorst,D. P. Engberts

Abstract:During the last century the patient-doctor relationship has changed considerably. This change becomes particularly visible when the relationship between the two parties is disturbed. this is usually caused by patient dissatisfaction with the doctor or other workers in the medical profession. Handling dissatisfaction should be part of a doctor's professional skills. The most important advice in dealing with dissatisfaction is to react fast. A doctor should have the good sense to raise the issue for discussion as soon as he/she senses signs of dissatisfaction. If this is not possible and the issue results in a written complaint, the plaintiff can lodge a complaint within the framework of a special law. The complaint is then handled by a complaints committee. Over the past years, mediation has been used increasingly. This procedure has a low threshold, works fast and often results in reconciliation of both parties. If the intervention of a complaints committee is not desired and mediation is not realistic or rejected, the case sometimes progresses to the disciplinary board or civil judge. This often leads to protracted procedures and is stressful to both parties. It is important to prevent these kinds of procedures as much as possible by reacting swiftly and appropriately to signs of dissatisfaction.
Lactoferrin regulates sebogenesis and inflammation in SZ95 human sebocytes and mouse model of acne

Yuan‐Ting Su,Wei Cui,An‐Ping Zhang

DOI: https://doi.org/10.1111/jocd.15577

2023-01-28

Journal of Cosmetic Dermatology

Abstract:Background The aim of this study was to explore the anti‐inflammatory and anti‐lipid effects of lactoferrin on SZ95 human sebaceous gland cells and mouse model of acne. Methods SZ95 cells were co‐cultured with different concentrations of lactoferrin, and cell viability was determined using the 2,5‐diphenyl‐2H‐tetrazolium bromide method. Oil red O and Nile red staining were performed to determine the lipid content. The mRNA expression of genes related to lipid metabolism (sterol regulatory element‐binding protein‐1 [SREBP‐1], fatty acid synthase [FAS], stearoyl‐CoA desaturase‐1 [SCD‐1], fatty acid desaturase 2 [FADS2]) and inflammation (interleukin‐8 [IL‐8]) was determined by reverse transcription–polymerase chain reaction. An acne mouse model was established using injection of P. acnes on the backs of mice. The proliferation and apoptosis of sebaceous gland cells were examined by immunohistochemistry against proliferating cell nuclear antigen (PCNA) and TUNEL staining, respectively. Western blotting was used to detect FADS2 and CXCL15 protein expression. Results Lactoferrin treatment at 10–500 μg/ml significantly decreased the lipid content, as revealed by the oil red O and Nile red staining. It also attenuated the increase of mRNA expression of SREBP‐1, FAS, SCD‐1, FADS2, and IL‐8 in insulin‐treated SZ95 cells. Moreover, lactoferrin treatment at the doses of 1–50 mg/mouse significantly reduced the inflammation and lipid production in the mouse model of acne. Also, the number of sebaceous gland cells was significantly reduced, and apoptosis was significantly increased by lactoferrin treatment in the mice. Mechanically, the levels of FADS2 and CXCL15 proteins in tissues were significantly decreased after lactoferrin treatment in the model mice. Conclusion Our results demonstrate the potential of lactoferrin against sebogenesis, sebaceous gland inflammation in acne.

dermatology
Suppression of Sebum Secretion with 13-cis-Retinoic Acid: Effect on Individual Skin Surface Lipids and Implications for Their Anatomic Origin

Mary Ellen Stewart,Allison M. Benoit,Donald T. Downing,John S. Strauss

DOI: https://doi.org/10.1111/1523-1747.ep12259161

IF: 7.59

1984-01-01

Journal of Investigative Dermatology

Abstract:The contribution of the keratinizing epidermis to the human skin surface lipid film has been difficult to ascertain because, after its release from the epidermal cells, epidermally derived lipid inevitably becomes mixed with sebum. In the present study, the sustainable rates of production of the 5 neutral lipid classes found on the skin surface (triglycerides + free fatty acids, wax esters, cholesterol, cholesterol esters, and squalene) were measured on the foreheads of acne patients before, during, and following treatment with 13-cis-retinoic acid, a drug which suppresses sebum production profoundly. Since sebum production was high in the patients before treatment and was suppressed to a few percent of the pretreatment level in some of the patients during treatment, data covering a wide range of sebum production rates were obtained. By using squalene as a measure of sebum production and plotting the rates of production of the other lipid classes vs the rate of production of squalene, it was possible through extrapolation to estimate the residual (i.e., epidermal) rate of production of each lipid class at zero sebum production. The results indicated that epidermis releases triglycerides + free fatty acids and cholesterol to the skin surface. The cholesterol esters in freshly secreted skin surface lipids appeared to be almost entirely sebaceous in origin. Measurements were also made of the percentages of cholesterol esters in lipid collected from the scalp after several days' accumulation and were compared to corresponding values for the forehead lipid. The percentages of cholesterol esters in scalp lipid tended to rise when sebum production was suppressed by the drug, rather than remaining relatively constant as occurred in the freshly secreted forehead lipid. This result indicated that epidermis may contribute to skin surface cholesterol esters, probably through skin surface esterification of epidermal cholesterol.

dermatology
Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention

Zhaoming Zhu,Tingting Chen,Zhuxian Wang,Yaqi Xue,Wenfeng Wu,Yuan Wang,Qunqun Du,Yufan Wu,Quanfu Zeng,Cuiping Jiang,Chunyan Shen,Li Liu,Hongxia Zhu,Qiang Liu

DOI: https://doi.org/10.3389/fphar.2021.700696

2021-09-01

Abstract:The label-free methods of proteomic combined with metabolomics were applied to explore the mechanisms of Cryptotanshinone (CPT) intervention in rats with acne. The model group consisted of rats given oleic acid (MC), then treated with CPT, while control groups did not receive treatment. The skin samples were significantly different between control, model and CPT-treated groups in hierarchical clustering dendrogram. Obvious separations of the skin metabolic profiles from the three groups were found through PCA scoring. In total, 231 and 189 differentially expressed proteins (DEPs) were identified in MC and CPT groups, respectively. By the KEGG analysis, five protein and metabolite pathways were found to be significantly altered. These played important roles in response to oleic acid-induced acne and drug treatment. CPT could negatively regulate glycolysis/gluconeogenesis and histidine metabolisms to decrease keratinocyte differentiation and improve excessive keratinization and cellular barrier function. CPT could down-regulate the IL-17 signaling pathway and regulate the acne-driven immune response of sebum cells. The biosynthesis of unsaturated fatty acids metabolism, glycerophospholipid metabolism and linoleic acid pathways could significantly alter sebum production and control sebaceous gland secretion after CPT treatment. The gap junction was up-regulated after CPT treatment and the skin barrier turned back to normal. Krt 14, Krt 16 and Krt 17 were significantly down-regulated, decreasing keratinization, while inflammatory cell infiltration was improved by down-regulation of Msn, up-regulation of linoleic acid and estrogen pathways after CPT treatment. These results propose action mechanisms for the use of CPT in acne, as a safe and potential new drug.
Peiminine Exerts Its Anti-Acne Effects by Regulating the NF-κB Pathway

So Jin Cha,Seon Sook Kim,Jin Hak Shin,Su Ryeon Seo

DOI: https://doi.org/10.3390/antiox13010131

IF: 7.675

2024-01-23

Antioxidants

Abstract:Peiminine is the main natural alkaloid compound extracted from the Chinese herb Fritillaria. Although peiminine is known for its antioxidant and anti-inflammatory effects in conditions such as mastitis and arthritis, its impact on inflammation induced by Cutibacterisum acnes (C. acnes) has not been explored. The aim of this study was to investigate the effect of peiminine on C. acnes-induced inflammatory responses in the skin and to identify the underlying mechanism involved. We discovered that peiminine inhibits the C. acnes-induced expression of inflammatory mediators such as pro-interleukin-1β (pro-IL-1β), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in mouse bone marrow-derived macrophages (BMDMs). Peiminine suppressed the activation of nuclear factor-kappa B (NF-κB) without affecting the activation of mitogen-activated protein kinase (MAPK) pathways such as JNK, ERK, and p38 MAPK. In addition, we found that peiminine suppressed inflammatory cytokine expression and ameliorated histological symptoms in C. acnes-induced mouse skin. Our study is the first to provide evidence that peiminine has an inhibitory effect on acne, and it points toward the potential of incorporating peiminine into cosmetic and pharmaceutical formulations for acne treatment.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Epidermal Growth Factor Modulates Palmitic Acid-Induced Inflammatory and Lipid Signaling Pathways in SZ95 Sebocytes

Dániel Törőcsik,Fruzsina Fazekas,Szilárd Póliska,Andrea Gregus,Eszter Anna Janka,Katalin Dull,Andrea Szegedi,Christos C. Zouboulis,Dóra Kovács

DOI: https://doi.org/10.3389/fimmu.2021.600017

IF: 7.3

2021-05-06

Frontiers in Immunology

Abstract:Epidermal growth factor (EGF) acts as a paracrine and autocrine mediator of cell proliferation and differentiation in various types of epithelial cells, such as sebocytes, which produce the lipid-rich sebum to moisturize the skin. However, sebum lipids via direct contact and by penetrating through the epidermis may have regulatory roles on epidermal and dermal cells as well. As EGF receptor (EGFR) is expressed throughout the proliferating and the lipid-producing layers of sebaceous glands (SGs) in healthy and acne-involved skin, we investigated the effect of EGF on SZ95 sebocytes and how it may alter the changes induced by palmitic acid (PA), a major sebum component with bioactive roles. We found that EGF is not only a potent stimulator of sebocyte proliferation, but also induces the secretion of interleukin (IL)6 and down-regulates the expression of genes involved in steroid and retinoid metabolism. Importantly, when applied in combination with PA, the PA-induced lipid accumulation was decreased and the cells secreted increased IL6 levels. Functional clustering of the differentially regulated genes in SZ95 sebocytes treated with EGF, PA or co-treated with EGF+PA further confirmed that EGF may be a potent inducer of hyperproliferative/inflammatory pathways (IL1 signaling), an effect being more pronounced in the presence of PA. However, while a group of inflammatory genes was up-regulated significantly in EGF+PA co-treated sebocytes, PA treatment in the absence of EGF, regulated genes only related to cell homeostasis. Meta-analysis of the gene expression profiles of whole acne tissue samples and EGF- and EGF+PA -treated SZ95 sebocytes showed that the EGF+PA co-activation of sebocytes may also have implications in disease. Altogether, our results reveal that PA-induced lipid accumulation and inflammation can be modulated by EGF in sebocytes, which also highlights the need for system biological approaches to better understand sebaceous (immuno)biology.

immunology
Ultraviolet spectrophotometric determination of chlorprothixene in biologic specimens.

J. Wallace

DOI: https://doi.org/10.1002/JPS.2600561113

1967-11-01

Journal of Pharmacy and Science

Abstract:A rapid spectrophotometric method for determining chlorprothixene permits analysis of the drug in biologic specimens in the presence of its metabolites and other alkaline drugs without preliminary separation. The procedure is based upon the oxidation of chlorprothixene and its immediate metabolites to a mixture of reaction products by means of alkaline permanganate. In hexane the products have a characteristic ultraviolet absorption curve with a well-defined maximum at 233 mμ. The strong absorption at this wavelength is utilized as a basis for the analytical procedure. The method is sufficiently sensitive for the determination of chlorprothixene in urine 3 days after the ingestion of a single 50-mg. dose. Observations concerning the distribution of chlorprothixene in the rat and the excretion of the drug in man are presented.
Zileuton, a new efficient and safe systemic anti-acne drug

Christos C. Zouboulis

DOI: https://doi.org/10.4161/derm.1.3.8368

2009-05-01

Abstract:Tissue inflammation is a major component of the acne process. Leukotriene B(4) (LTB(4)) is considered to be a major player in the development of tissue inflammation. Synthesis of LTB(4) is controlled by the enzyme 5-lipoxygenase. Since Zileuton blocks the activity of 5-lipoxygenase, experimental and clinical studies have been conducted to test mode of function, as well as efficacy and safety of this compound in the treatment of acne vulgaris. Human SZ95 sebocytes and inflammatory cells in vitro express the enzymes of the leukotriene pathway at mRNA and protein levels and enzymes involved in the biosynthesis of LTB(4) are activated in sebaceous glands of acne lesions. Pre-treatment of SZ95 sebocytes with Zileuton partially prevented short-term arachidonic acid-induced effects, such as induction of LTB(4), increase of neutral lipid content and stimulation of interlekin-6 release. Long-term treatment with Zileuton directly reduced the content of neutral lipids and interleukin-6 release from SZ95 seb ocytes. PPAR mRNA levels were not regulated by Zileuton. In a first pilot clinical study with 10 patients with papulopustular acne Zileuton 4 x 600 mg/d p.o. for 3 months decreased the acne severity index in a time-dependent manner being 41% of the initial score at week 12 (p < 0.05). This was mostly due to a decrease of the number of inflammatory lesions of 29% (p < 0.01). In addition, total sebum lipids significantly decreased (35%, p < 0.05) and the pro-inflammatory free fatty acids (22%) and lipoperoxides (26%) were markedly diminished in patients' sebum under treatment. The magnitude of clinical improvement strongly correlated with the reduction of total sebum lipids (p = 0.0009, r(2) = 0.81) and free fatty acids (p = 0.0003, r(2) = 0.82). In a further study, a 40-year-old female with mild disseminated sebaceous gland hyperplasia and seborrhea, responded with normalization of the casual skin surface lipids and similar reduction of facial sebum synthesis under treatment with Zileuton over 2weeks and-after a wash-out phase-low-dose isotretinoin (10 mg/2nd d) over 5 weeks. These data are in agreement with a phase II multicenter, clinical study in 101 patients with mild to moderate inflammatory facial acne conducted in the US, which showed a significant efficacy of Zileuton in a subset of patients with moderate acne, whereas those patients treated with Zileuton showed a significant mean decrease in inflammatory lesions compared to the placebo group. In all clinical studies, Zileuton was found to be safe and well tolerated.
A dysregulated sebum–microbial metabolite–IL-33 axis initiates skin inflammation in atopic dermatitis

Zhuoqiong Qiu,Zhenlai Zhu,Xiaochun Liu,Baichao Chen,Huibin Yin,Chaoying Gu,Xiaokai Fang,Ronghui Zhu,Tianze Yu,Wenli Mi,Hong Zhou,Yufeng Zhou,Xu Yao,Wei Li

DOI: https://doi.org/10.1084/jem.20212397

2022-08-16

Abstract:Microbial dysbiosis in the skin has been implicated in the pathogenesis of atopic dermatitis (AD); however, whether and how changes in the skin microbiome initiate skin inflammation, or vice versa, remains poorly understood. Here, we report that the levels of sebum and its microbial metabolite, propionate, were lower on the skin surface of AD patients compared with those of healthy individuals. Topical propionate application attenuated skin inflammation in mice with MC903-induced AD-like dermatitis by inhibiting IL-33 production in keratinocytes, an effect that was mediated through inhibition of HDAC and regulation of the AhR signaling pathway. Mice lacking sebum spontaneously developed AD-like dermatitis, which was improved by topical propionate application. A proof-of-concept clinical study further demonstrated the beneficial therapeutic effects of topical propionate application in AD patients. In summary, we have uncovered that the dysregulated sebum–microbial metabolite–IL-33 axis might play an initiating role in AD-related skin inflammation, thereby highlighting novel therapeutic strategies for the treatment of AD.

immunology,medicine, research & experimental
Adapalene suppresses sebum accumulation via the inhibition of triacylglycerol biosynthesis and perilipin expression in differentiated hamster sebocytes in vitro

Takashi Sato,Noriko Akimoto,Kimiko Kitamura,Hirokazu Kurihara,Nobukazu Hayashi,Akira Ito

DOI: https://doi.org/10.1016/j.jdermsci.2013.02.003

Abstract:Background: Acne is a chronic inflammatory disease in sebaceous glands and pilosebaceous units where excess sebum production and follicular hyperkeratinization are observed. Adapalene, which exerts comedolytic and anti-inflammatory effects, is used for the topical treatment of mild to moderate acne. Objective: We examined the effect of adapalene on sebum production and accumulation in sebaceous gland cells (sebocytes). Methods: The regulation of sebum production was examined by oil red O and nile red staining and the measurement of triacylglycerols (TGs) in differentiated hamster sebocytes. The gene expression and production of diacylglycerol acyltransferase-1 (DGAT-1) and perilipin 1 (PLIN1) were analyzed using real-time PCR and Western blotting, respectively. Results: Adapalene suppressed sebum accumulation as lipid droplets in spontaneously and insulin-differentiated hamster sebocytes. The TG production, and the gene expression and production of DGAT-1, a rate-limiting enzyme of TG biosynthesis, were dose-dependently inhibited by adapalene in insulin-, 5α-dihydrotestosterone- or a peroxisome proliferator activating receptor γ agonist, troglitazone-differentiated hamster sebocytes. In addition, the inhibition of TG production by adapalene interfered with antagonists against nuclear retinoic acid and retinoid X receptors (CD2665 and UVI3006, respectively) in the differentiated sebocytes. Furthermore, the production of PLIN1, a lipid storage droplet protein, was transcriptionally inhibited by adapalene in the differentiated sebocytes. Conclusions: These results suggest that adapalene exerts an inhibitory action for sebum accumulation due to the suppression of TG and PLIN1 production in differentiated hamster sebocytes. Furthermore, these findings may contribute to a novel understanding of the molecular mechanisms of adapalene for acne treatment and prevention.
Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes

James A Sanford,Alan M O'Neill,Christos C Zouboulis,Richard L Gallo,James A. Sanford,Alan M. O’Neill,Christos C. Zouboulis,Richard L. Gallo

DOI: https://doi.org/10.4049/jimmunol.1800893

2019-02-08

The Journal of Immunology

Abstract:The regulation of cutaneous inflammatory processes is essential for the human skin to maintain homeostasis in the presence of the dense communities of resident microbes that normally populate this organ. Forming the hair follicle–associated sebaceous gland, sebocytes are specialized lipid-producing cells that can release inflammatory mediators. Cytokine and chemokine expression by pilosebaceous epithelial cells (i.e., sebocytes and follicular keratinocytes) has been proposed to contribute to the common human skin disease acne vulgaris. The underlying mechanisms that drive inflammatory gene expression in acne-involved pilosebaceous epithelial cells are still unknown because almost all sebaceous follicles contain dense concentrations of bacteria yet only some show an inflammatory reaction. In this study, we hypothesized that metabolites from the abundant skin-resident microbe Propionibacterium acnes can influence cytokine expression from human sebocytes. We show that short-chain fatty acids produced by P. acnes under environmental conditions that favor fermentation will drive inflammatory gene expression from sebocytes. These molecules are shown to influence sebocyte behavior through two distinct mechanisms: the inhibition of histone deacetylase (HDAC) activity and the activation of fatty acid receptors. Depletion of HDAC8 and HDAC9 in human sebocytes resulted in an enhanced cytokine response to TLR-2 activation that resembled the transcriptional profile of an acne lesion. These data provide a new insight into the regulation of inflammatory gene expression in the skin, further characterize the contribution of sebocytes to epidermal immunity, and demonstrate how changes in the metabolic state of the skin microbiome can promote inflammatory acne.

immunology
[A familial study of methemoglobinemia].

H. Ohkuwa,E. Takazakura,Y. Terada,H. Makino,K. Tanishima,Y. Yoneyama

DOI: https://doi.org/10.2169/NAIKA.75.426

1986-03-01

Abstract:
Aryl Hydrocarbon Receptor Modulates the Expression of TNF-α and IL-8 in Human Sebocytes via the MyD88-p65NF-κB/p38MAPK Signaling Pathways

Xiao-Xiao Hou,Guangjie Chen,Amir M Hossini,Tingting Hu,Lanqi Wang,Zhanyan Pan,Lingyi Lu,Ke Cao,Ying Ma,Christos C Zouboulis,Longqing Xia,Qiang Ju

DOI: https://doi.org/10.1159/000491029

Abstract:Activation of Toll-like receptor (TLR)-2 and subsequent inflammatory response contribute to lesion development in acne vulgaris. A cross-talk between aryl hydrocarbon receptor (AhR), a cytosolic receptor protein that responds to environmental and physiological stress, and TLRs has recently been reported. In this study, we explored the possible role of AhR in the effects induced on cultured human SZ95 sebocytes by peptidoglycan (PGN), a classic TLR2 agonist. PGN-induced secretion of inflammatory factors TNF-α and IL-8 in human SZ95 sebocytes was suppressed after knockdown of AhR and pretreatment with the AhR antagonist CH223191. In addition, the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) enhanced TNF-α and IL-8 secretion in PGN-pretreated sebocytes. Furthermore, PGN-induced expression of myeloid differentiation factor 88 (MyD88), phospho-p38MAPK (p-p38MAPK), and p-p65NF-κB was strengthened by TCDD and repressed by CH223191. AhR inhibition by transfecting shRNA blocked the ability of PGN to stimulate phosphorylation of p38MAPK and p65NF-κB in SZ95 sebocytes. Overall, these data demonstrate that AhR is able to modulate PGN-induced expression of TNF-α and IL-8 in human SZ95 sebocytes involving the MyD88-p65NF-κB/p38MAPK signaling pathway, which probably indicates a new mechanism in TLR2-mediated acne.

[Evaluation of fifteen months' activity in an ambulatory surgery center in a university hospital].

Azidothymidine Downregulates Insulin-Like Growth Factor-1 Induced Lipogenesis by Suppressing Mitochondrial Biogenesis and Mitophagy in Immortalized Human Sebocytes

Conscious mind as a field.

Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili

Paeoniflorin mitigates insulin-like growth factor 1-induced lipogenesis and inflammation in human sebocytes by inhibiting the PI3K/Akt/FoxO1 and JAK2/STAT3 signaling pathways

Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes

Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro

Formalin-killed Propionibacterium acnes activates the aryl hydrocarbon receptor and modifies differentiation of SZ95 sebocytes in vitro

[Dealing with patient dissatisfaction; a professional skill].

Lactoferrin regulates sebogenesis and inflammation in SZ95 human sebocytes and mouse model of acne

Suppression of Sebum Secretion with 13-cis-Retinoic Acid: Effect on Individual Skin Surface Lipids and Implications for Their Anatomic Origin

Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention

Peiminine Exerts Its Anti-Acne Effects by Regulating the NF-κB Pathway

Epidermal Growth Factor Modulates Palmitic Acid-Induced Inflammatory and Lipid Signaling Pathways in SZ95 Sebocytes

Ultraviolet spectrophotometric determination of chlorprothixene in biologic specimens.

Zileuton, a new efficient and safe systemic anti-acne drug

A dysregulated sebum–microbial metabolite–IL-33 axis initiates skin inflammation in atopic dermatitis

Adapalene suppresses sebum accumulation via the inhibition of triacylglycerol biosynthesis and perilipin expression in differentiated hamster sebocytes in vitro

Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes

[A familial study of methemoglobinemia].

Aryl Hydrocarbon Receptor Modulates the Expression of TNF-α and IL-8 in Human Sebocytes via the MyD88-p65NF-κB/p38MAPK Signaling Pathways